GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,650.50
Bid: 1,652.00
Ask: 1,652.50
Change: 35.50 (2.20%)
Spread: 0.50 (0.03%)
Open: 1,631.00
High: 1,663.50
Low: 1,630.50
Prev. Close: 1,615.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q&A-Pound plunges, stocks up, economy flat: What do Brexit swings mean for you?

Fri, 07th Oct 2016 08:35

By Guy Faulconbridge, Jamie McGeever and David Milliken

LONDON, Oct 7 (Reuters) - Sterling has tumbled to a 31-yearlow, but British stocks are near a record high and, contrary tomany expert forecasts, the shock of Brexit has not yet pushedthe British economy off a cliff.

So what gives?

Depending on which part of the financial universe you lookat, the outlook for UK Plc following the June 23 vote to leavethe European Union can appear equally bright or bleak.

Sterling's plunge makes Britain's exports more competitiveon global markets and is therefore a boost for economic growth.But if sustained, it will fuel inflation and become a source ofworry at the Bank of England.

How does the rest of the world measure Britain's standing asit prepares to divorce from the EU? Which is more telling: thesteep decline in the currency's value, or the recovery in thestock markets and competitiveness?

Below is a guide to what has happened across UK markets andthe economy since the Brexit vote, what lies ahead and what itmeans for Britain.

For full coverage click on the Brexit page: http://emea1.apps.cp.extranet.thomsonreuters.biz/cms/?pageId=brexit&navid=15301

For a weekly round-up of Brexit news: http://share.thomsonreuters.com/assets/newsletters/Specialpackages/Brexit_October5.pdf

WHAT HAS THE IMPACT BEEN SO FAR?

- CURRENCY: Sterling, which traded as high as $1.50on June 23, was last fetching $1.2440.

In early Asian trade on Friday, sterling plunged about 10percent at one point to $1.1378 from around $1.2600, though theoutlying trade was later cancelled and the low was revised to$1.1491 - still, the weakest level for sterling since 1985.

Sterling hit a five-year low against the euro and its loweston a trade-weighted basis since January 2009, in the depths ofthe Great Financial Crisis. It is within a couple of percent offalling to its lowest since at least the 1970s on atrade-weighted basis.

Currency traders have shunned the pound on fears Britaincould be heading towards a so called "hard Brexit" that willinvolve a turbulent negotiation with the other 27 members of theEU resulting in Britain losing its preferential access to theEU's single market while imposing immigration controls.

- SHARES: Britain's FTSE 100 index was up 0.4percent at 7,030.30 points by 0712 GMT, less than 100 pointsaway from its life-time high set in April last year. The indexis up nearly 2 percent so far this week after falling in theprevious week

The blue-chip index has risen 10 percent since itspre-Brexit level - and more than 15 percent from its post-Brexitlow - and has come within a whisker of its historic high of7,122.74.

The FTSE 250, which measures the value of smallerand more domestic-focused firms, hit a record high of 18,607points this week and is up more than 20 percent from thepost-Brexit low of June 27.

The rally in stocks has been fuelled by the BoE's policyresponse and the slump in sterling. A weaker exchange rateboosts the earnings of companies with global operations, andaround 75 percent of FTSE 100 firms' earnings are derived fromabroad.

By contrast, in dollar terms - which is how non-UK investorsmeasure their results - the FTSE 100 is still 8 percent lowerthan it was the day of the referendum and the FTSE 250 is down12 percent.

- BONDS: The 10-year gilt yield touched 0.954percent on Friday, its highest level since June 30 and laststood at 0.949 percent. It was 1.40 percent the day of theBrexit referendum.

But investors are now selling long-dated British governmentdebt, worried by a rise in inflation that is expected to followthe fall in the value of the pound.

- MONETARY POLICY: The Bank of England cut rates on Aug. 4 to the lowest in its 322-year history and unleashed billions ofpounds worth of extra stimulus.

PM May took the unusual step of commenting on central bankpolicy on Wednesday when she said near-zero rates and the BoE'shuge bond-buying programme had hurt savers.

WHAT LIES AHEAD?

STERLING

BoE Deputy governor Ben Broadbent said on Wednesday that thepound's decline so far had been "pretty orderly, actually". Butthat was before the pound plunged 6 percent in just two minutesearly on Friday.

Volatility like that is bound to raise the ghosts of"sterling crisis" past, namely 1967, 1976 and 1992. Mostobservers say we're not there yet, but markets are nervous.

Sterling will remain extremely sensitive to statements fromPrime Minister Theresa May, her ministers and European leaderson how the Brexit process unfolds.

Lawmakers from PM May's ruling Conservative Party say thefall in sterling has made Britain more competitive, but manyfinancial market analysts say it reflects the negative view therest of the world has of Brexit Britain.

The next major step in the Brexit process will be when Maysends, by the end of March, a formal notification to the EU thatBritain is preparing to leave, invoking Article 50 of the EU'sLisbon Treaty. That starts a two-year negotiating window beforethe United Kingdom should leave.

Still, politics could intervene: the U.S. presidentialelection takes place on November 8, Italy faces a referendum onDec. 4, France holds a presidential election on April 23 and May7 and Germany holds an election in September 2017.

Just because the pound has fallen sharply in the last threemonths, there's no reason it should automatically recover. Someinvestors have even raised the idea of parity with the dollar.

STOCKS

Central to Britain's stock market direction in the comingmonths is the exchange rate. As long as the pound remains weak,equity valuations will be revised higher. If you take the viewthat sterling will remain weak, earnings will be higher.

UK stocks are trading in a binary fashion - sterling falls,stocks rise. And vice versa. There is no sign of a "buyers'strike" hitting UK stocks or bonds right now because the BoE ishappy letting the pound take the strain as it boosts exports,and helps narrow the trade and current account deficits.

The exchange rate moves also make British companies moreattractive takeover targets for foreign firms, potentiallyfuelling a mergers and acquisition wave that would boost thevalue of UK shares.

But if, in the words of BoE governor Mark Carney, a countrydepends on "the kindness of strangers", you have to be carefulabout your currency. There may come a point when foreigninvestors take fright at sterling and stop buying UK assets.

A Reuters poll of around 30 traders, fund managers andstrategists this week predicted that the FTSE 100 will loseground over the coming year.

BANK OF ENGLAND

The Bank said in August and again in September that most ofits policymakers expected to cut rates again this year if theeconomy looked on track to slow as it had forecast.

However, Prime Minister May's comments on the damagingside-effects of his ultra-low interest rates stunned investors.

The blunt words represented a clear change of tone fromDowning Street, under its new occupant, towards the Bank ofEngland and were among the most direct from a prime ministersince the BoE won operational independence in 1997.

Carney said on Thursday he agreed "with the spirit" of May'sspeech in which she signalled action by the government to fostergrowth and said the BoE's actions had helped the economy throughthe aftermath of the 2007-09 financial crisis.

Stronger than expected recent data puts Carney in a trickyposition.

While weakening the immediate case for a further rate cut -especially as soon as next month - it is less clear whether itwill alter the BoE's longer-run expectation of a slump inbusiness investment and a gentler slowdown in consumer spending.

COMPANIES

The current consensus is that British-based companies thatearn in currencies other than the pound - such as BritishAmerican Tobacco, GlaxoSmithKline Plc - shoulddo well as their revenues will be reported in pounds.

Those reliant on domestic revenues - such as retailers - areexposed should the British economy take a hit. While recent datahas shown the economy shrugged off some the shock of the Brexitvote, the Bank of England downgraded its 2017 growth forecast tojust 0.8 percent from a previous estimate of 2.3 percent. Thegrowth outlook for 2018 was cut to 1.8 percent.

Supermarkets such as no.2 player Sainsbury's have saidsterling's fall since the Brexit will not necessarily lead tohigher grocery prices, as it could be offset by lowercommodities prices and stiff competition.

Travel companies TUI Group and Thomas Cook have seen bookings from UK customers rise this summer, asBritons defied worries that the devaluation of the pound woulddeter people from going on holidays abroad.

The swings in the price of sterling may force some companiesto hedge their currency exposure while prompting demands for payrises from workers who earn in sterling but have dollar or eurocosts.

INFLATION

Economists estimate that a sustained 10 percent fall in thepound's exchange rate adds about 0.2-0.3 percentage points toinflation over the period of a couple of years.

The Bank of England forecasts inflation will rebound toaround its 2 percent target next year and then overshoot to 2.4percent in 2018 and 2019 - the biggest medium-term overshoot ithas ever forecast.

Some banks predict a bigger, but shorter-lived, spike ininflation next year as the effects of a weaker currency passthrough more quickly to the rest of the economy than the BoEexpects.

Retailers have given a mixed picture on how soon they willpass on price rises. Some, such as fashion retailer Next havesaid they plan to raise prices rather than erode margins.

But other sectors such as groceries see differentcompetitive pressures.

While the fall in sterling should make imported food moreexpensive, Britain's biggest retailer, Tesco, sees nolet up in deflation in the UK grocery market any time soon.

A survey published by the British Retail Consortium reporteda record drop in the cost of food and found little sign of pricerises on the back of sterling's fall since the Brexit vote.

M&A

The shock vote to leave the EU chilled dealmaking activityinvolving British companies to the lowest level in at least twodecades as bosses grapple with what Brexit will cost, ThomsonReuters data shows.

BRITAIN'S PLACE IN THE WORLD

The United Kingdom's gross domestic product, forecast beforethe June 23 vote to be worth about $2.8 trillion in 2016, or theworld's fifth largest, has now slipped behind France.

Its GDP is now worth about $2.32 trillion on currentexchange rates, compared with France's $2.34 trillion. Germanyis the EU's largest economy, worth about $3.5 trillion, and theworld's fourth largest economy after the United States, Chinaand Japan. (Writing by Jamie McGeever, Guy Faulconbridge, David Milliken,Sarah Young; Editing by Toby Chopra)

More News
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.